CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BluSense Diagnostics has created a rapid blood testing platform for dengue fever detection using nanotechnology. This platform allows for accurate diagnosis from a single drop of blood, aiming to improve treatment in regions affected by dengue.
BluSense Diagnostics has developed an innovative nanotechnology-based point-of-care blood testing platform for detecting dengue fever.
With a single drop of blood, we can within minutes and with very high accuracy, test whether patients have been infected with dengue fever.
The technology will be a major step forward in the treatment of dengue in areas around the world, where dengue is a serious threat.
In 2016, more than 330m people were tested positive for dengue, and the number is growing.
Ou…
BLUSENSE DIAGNOSTICS APS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
